# ZEVTERA

NDC: 68547-578
Generic name: ceftobiprole medocaril sodium
Labeler / Manufacturer: La Jolla Pharmaceutical Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250401

FDA application: NDA218275

## Active ingredients

- CEFTOBIPROLE MEDOCARIL SODIUM: 667 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68547-578"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68547-578
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bd685df-7dc6-78a6-e063-6294a90a580b